Literature DB >> 2864579

Malignant melanoma in Scotland 1979-1983.

R M MacKie, J F Smyth, D S Soutar, K C Calman, A C Watson, J A Hunter, K M McLaren, J B MacGillivray, J L McPhie, R Rankin.   

Abstract

1318 cases of primary malignant melanoma of the skin first presenting in Scotland in the years 1979-83 and registered with the Scottish Melanoma Group are described. The annual age-adjusted incidence rate is 4.75 per 100 000 for females and 2.77 per 100 000 for males. Incidence rose by an annual average of 2.5% over the five-year period. The female: male ratio was 2:1, and 48.5% of all cases were of the superficial spreading histogenetic variety. Five-year survival rates for the patients registered in 1979 confirm the prognostic value of the tumour-thickness (Breslow) measurement. They were 93% for patients with tumours less than 1.5 mm thick (39% of patients), 67% for those with tumours 1.5-3.49 mm thick (30%), and 37% for those with tumours thicker than 3.5 mm (31%). This study shows that methods for early recognition of thin tumours should be encouraged.

Entities:  

Mesh:

Year:  1985        PMID: 2864579     DOI: 10.1016/s0140-6736(85)90126-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  14 in total

1.  Effect of rapid referral on thickness of melanomas.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-27

2.  Reasons for poor prognosis in British patients with cutaneous malignant melanoma.

Authors:  V R Doherty; R M MacKie
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-12

3.  Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions?

Authors:  R Philipp; A Hastings; J Briggs; J Sizer
Journal:  J Epidemiol Community Health       Date:  1988-03       Impact factor: 3.710

4.  Tumor thickness is not a prognostic factor in thin melanoma.

Authors:  C Kuehnl-Petzoldt; S Fischer
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Experience of a public education programme on early detection of cutaneous malignant melanoma.

Authors:  V R Doherty; R M MacKie
Journal:  BMJ       Date:  1988-08-06

6.  Increased incidence of malignant melanoma of the skin in workers in a telecommunications industry.

Authors:  L De Guire; G Theriault; H Iturra; S Provencher; D Cyr; B W Case
Journal:  Br J Ind Med       Date:  1988-12

7.  Importance of polymorphisms in NF-kappaB1 and NF-kappaBIalpha genes for melanoma risk, clinicopathological features and tumor progression in Swedish melanoma patients.

Authors:  Huajie Bu; Inger Rosdahl; Xiao-Feng Sun; Hong Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-11       Impact factor: 4.553

8.  Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia.

Authors:  D R English; B K Armstrong
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

9.  Use of host factors to identify people at high risk for cutaneous malignant melanoma .

Authors:  L D Marrett; W D King; S D Walter; L From
Journal:  CMAJ       Date:  1992-08-15       Impact factor: 8.262

10.  No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.

Authors:  Annika Schäfer; Steffen Emmert; Jochen Kruppa; Steffen Schubert; Mladen Tzvetkov; Rotraut Mössner; Kristian Reich; Carola Berking; Matthias Volkenandt; Claudia Pföhler; Michael P Schön; Thomas Vogt; Inke R König; Jörg Reichrath
Journal:  Arch Dermatol Res       Date:  2012-05-11       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.